505 S FRIENDSWOOD DRIVE, FRIENDSWOOD, TX
Castle Biosciences Elects Three Directors at 2026 Annual Meeting
Reports First Quarter 2026 Results
Annual Report to Security Holders
Reports Fourth Quarter and Full–Year 2025 Results
Announces Preliminary Unaudited Fourth Quarter and Full–Year 2025 Results
Reports Third Quarter 2025 Results
Amendments to Articles of Incorporation or Bylaws
Reports Second Quarter 2025 Results
Q1
FY 2024
Q3
Q2
Registration Statement for Securities to be Offered to Employees
Effectiveness Notice
Registration Statement for Securities Offered under a Shelf Registration
Additional Proxy Materials
Definitive Proxy Statement
PRE 14A
Statement of Changes in Beneficial Ownership
Notice of Proposed Sale of Securities
Correspondence
Submission Upload
Amended Notice of Proposed Sale of Securities
S-1MEF